Search papers, labs, and topics across Lattice.
The paper introduces GenomeQA, a benchmark for evaluating general-purpose LLMs on sequence-based genome inference tasks using raw DNA sequences. The benchmark comprises 5,200 samples across six task families, including enhancer/promoter identification and transcription factor binding site prediction. Experiments with six frontier LLMs show that while they outperform random baselines and exploit local sequence signals, performance degrades on tasks requiring more complex inference.
General-purpose LLMs can extract some signal directly from raw DNA sequences, but still struggle with complex genomic inference, highlighting a gap between their capabilities and the demands of real-world genomic analysis.
Large Language Models (LLMs) are increasingly adopted as conversational assistants in genomics, where they are mainly used to reason over biological knowledge, annotations, and analysis outputs through natural language interfaces. However, existing benchmarks either focus on specialized DNA models trained for sequence prediction or evaluate biological knowledge using text-only questions, leaving the behavior of general-purpose LLMs when directly exposed to raw genome sequences underexplored. We introduce GenomeQA, a benchmark designed to provide a controlled evaluation setting for general-purpose LLMs on sequence-based genome inference tasks. GenomeQA comprises 5,200 samples drawn from multiple biological databases, with sequence lengths ranging from 6 to 1,000 base pairs (bp), spanning six task families: Enhancer and Promoter Identification, Splice Site Identification, Taxonomic Classification, Histone Mark Prediction, Transcription Factor Binding Site Prediction, and TF Motif Prediction. Across six frontier LLMs, we find that models consistently outperform random baselines and can exploit local sequence signals such as GC content and short motifs, while performance degrades on tasks that require more indirect or multi-step inference over sequence patterns. GenomeQA establishes a diagnostic benchmark for studying and improving the use of general-purpose LLMs on raw genomic sequences.
